Transcriptional silencing of the TFPI-2 gene by promoter hypermethylation was recently demonstrated in human glioma cells and choriocarcinoma cells (Hube et al, 2003b; Konduri et al, 2003). This evidence concerns the gene TFPI2 and central nervous system cancer.